Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mufiza Farid-Kapadia

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Systematic Reviews|March 7, 2017
Are child-centric aspects in newborn and child health systematic review and meta-analysis protocols and reports adequately reported?-two systematic reviewsMufiza Farid-Kapadia, Kariym C Joachim, Chrinna Balasingham, et al.
Journal of Clinical Epidemiology|December 2, 2017
Comparative evidence on harms in pediatric randomized clinical trials from less developed versus more developed countries is limitedDario Tedesco, Mufiza Farid-Kapadia, Martin Offringa, et al.
BMC Pediatrics|March 7, 2017
Do systematic reviews on pediatric topics need special methodological considerations?Mufiza Farid-Kapadia, Lisa Askie, Lisa Hartling, et al.
Future Oncology (London, England)|June 7, 2023
Comparison of tumor-agnostic and tumor-specific clinical oncology trial designs: a systematic review and meta-analysisMufiza Farid-Kapadia, Madelyn Barton, Zoe Bider-Canfield, et al.
CMAJ Open|October 3, 2019
Breast cancer risk and breast screening for trans people: an integration of 3 systematic reviewsOlivia Meggetto, Leslea Peirson, Mafo Yakubu, et al.
Cancers|June 26, 2026
Transarterial Chemoembolization Versus Transarterial Radioembolization in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trial EvidencePriyanka Gogna, Cindy Wang, Dex Underwood, et al.
Developmental Medicine and Child Neurology|August 3, 2019
Core outcome set for children with neurological impairment and tube feedingKariym C Joachim, Mufiza Farid-Kapadia, Nancy J Butcher, et al.
Journal of Biopharmaceutical Statistics|January 13, 2023
Advancing drug development in pediatric oncology, a focus on cancer biology and targeted therapies: iMATRIX platformMarianne Uguen, Magalie Hilton, Mufiza Farid-Kapadia, et al.
The Lancet. Oncology|November 30, 2019
Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1-2 studyBirgit Geoerger, C Michel Zwaan, Lynley V Marshall, et al.
Future Oncology (London, England)|November 24, 2025
LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancersMasafumi Ikeda, Marcus-Alexander Wörns, Mehmet Akce, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Systematic Reviews|March 7, 2017
Are child-centric aspects in newborn and child health systematic review and meta-analysis protocols and reports adequately reported?-two systematic reviewsMufiza Farid-Kapadia, Kariym C Joachim, Chrinna Balasingham, et al.
Journal of Clinical Epidemiology|December 2, 2017
Comparative evidence on harms in pediatric randomized clinical trials from less developed versus more developed countries is limitedDario Tedesco, Mufiza Farid-Kapadia, Martin Offringa, et al.
BMC Pediatrics|March 7, 2017
Do systematic reviews on pediatric topics need special methodological considerations?Mufiza Farid-Kapadia, Lisa Askie, Lisa Hartling, et al.
Future Oncology (London, England)|June 7, 2023
Comparison of tumor-agnostic and tumor-specific clinical oncology trial designs: a systematic review and meta-analysisMufiza Farid-Kapadia, Madelyn Barton, Zoe Bider-Canfield, et al.
CMAJ Open|October 3, 2019
Breast cancer risk and breast screening for trans people: an integration of 3 systematic reviewsOlivia Meggetto, Leslea Peirson, Mafo Yakubu, et al.
Cancers|June 26, 2026
Transarterial Chemoembolization Versus Transarterial Radioembolization in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trial EvidencePriyanka Gogna, Cindy Wang, Dex Underwood, et al.
Developmental Medicine and Child Neurology|August 3, 2019
Core outcome set for children with neurological impairment and tube feedingKariym C Joachim, Mufiza Farid-Kapadia, Nancy J Butcher, et al.
Journal of Biopharmaceutical Statistics|January 13, 2023
Advancing drug development in pediatric oncology, a focus on cancer biology and targeted therapies: iMATRIX platformMarianne Uguen, Magalie Hilton, Mufiza Farid-Kapadia, et al.
The Lancet. Oncology|November 30, 2019
Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1-2 studyBirgit Geoerger, C Michel Zwaan, Lynley V Marshall, et al.
Future Oncology (London, England)|November 24, 2025
LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancersMasafumi Ikeda, Marcus-Alexander Wörns, Mehmet Akce, et al.
Pageof 2